The tissue renin-angiotensin-aldosterone system in diabetes mellitus.
Authors:
- 1 April 2004
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 6 (2) , 98-105
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Dual Inhibition of β-Adrenergic and Angiotensin II Receptors by a Single AntagonistCirculation, 2003
- Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic NephropathyHypertension, 2003
- Dosing angiotensin II blockers—beyond blood pressureNephrology Dialysis Transplantation, 1999
- Renin-Angiotensin-Aldosterone-Kinin System Influences on Diabetic Vascular Disease and CardiomyopathyMineral and Electrolyte Metabolism, 1998
- Angiotensin II Increases Vascular Permeability Factor Gene Expression by Human Vascular Smooth Muscle CellsHypertension, 1995
- Pathophysiological Significance of Plasma Total Renin and Prorenin in Patients with Diabetes Mellitus.Endocrine Journal, 1995
- Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling.Hypertension, 1994
- Renin and angiotensinogen expression during the evolution of diabetes.Hypertension, 1992
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.Journal of Clinical Investigation, 1985